Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage.
暂无分享,去创建一个
L. Jeng | M. Ho | Pei-Jer Chen | Chun-Jen Liu | Po-Huang Lee | R. Hu | D. Lin | Wei-Chen Lee | Cheng‐Chung Wu | C. Peng | Ming-Chin Yu | H. Yeh | Sheng-Shun Yang | P. Lin | S. Chang | K. Mok | Kuan-Lang Lai | C. Lee | Pei‐Jer Chen